Six years’ experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias

Six years’ experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias

Abstract Background In 2013, our laboratory designed a targeted sequencing panel, “LipidSeq”, to study the genetic determinants of dyslipidemia and metabolic disorders. Over the last 6 years, we have analyzed 3262 patient samples obtained from our own Lipid Genetics Clinic and international colleagu...

Full description

Bibliographic Details
Main Authors: Jacqueline S. Dron, Jian Wang, Adam D. McIntyre, Michael A. Iacocca, John F. Robinson, Matthew R. Ban, Henian Cao, Robert A. Hegele
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Medical Genomics
Subjects:
Targeted next-generation sequencing panel
Familial hypercholesterolemia
Hypertriglyceridemia
Dyslipidemia
Metabolic disorder
Lipid
Online Access:https://doi.org/10.1186/s12920-020-0669-2

Internet

https://doi.org/10.1186/s12920-020-0669-2

Similar Items